On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the Institute of Synthetic Biology of Chinese Academy of Sciences – Shenzhen Institutes of Advanced Technology and the College of Life Science and Technology of Beijing University of Chemical Technology to conduct a study for mining immunogenic information from 39 COVID-19 patients in Hong Kong.

The study analysed and tested immunogenic information of SARS-CoV-2 Spike protein, and then discussed the feasibility of rational design of vaccine against SARS-CoV-2 by using the information. The results are now published in life sciences journal Cell Research